Latest News
WhiteFiber Q1 Results Due as NC-1 Data Center Revenue Ramp Begins
WhiteFiber reports Q1 earnings May 14 as its NC-1 data center begins billing under a $865M Nscale colocation deal. Revenue rose 61% in Q4 to $23.6M, but net loss was $1.5M.
Rocket Lab Soars 34% on Record Revenue, $2.2B Backlog
Rocket Lab shares surged 34% to a record after Q1 revenue jumped 63.5% to $200.3 million, driven by a $2.2 billion launch backlog and key defense contracts.
AST SpaceMobile Earnings on Deck After FCC License and Launch Setback
AST SpaceMobile reports Q1 earnings Monday after securing an FCC license for a 248-satellite direct-to-phone network, but a Blue Origin launch failure left its BlueBird 7 satellite in an unusable orbit.
Digi Power X's $175M ATM Plan Raises Stakes for Cerebras AI Data Center Deal
Digi Power X Inc. expands its ATM share program to $175M to fund a 40-MW AI data center deal with Cerebras Systems, as investors eye execution risks and dilution.
Novo Nordisk Stock Climbs as Ozempic Study Shows 15.4% Weight Loss in Seniors
Novo Nordisk B shares gained 3.75% in Copenhagen after a pooled analysis revealed semaglutide 2.4 mg resulted in 15.4% weight loss in older adults, reinforcing the company's obesity portfolio.
Circle Faces Q1 Earnings Test Amid Shifting Stablecoin Regulations
Circle Internet Group reports Q1 earnings Monday before the market opens, with analysts expecting $0.19 EPS and $715M revenue, as USDC circulation surged 72%.
POET Technologies Hit by Lawsuit After Marvell Cancels Celestial AI Orders
POET Technologies faces a securities class action after Marvell canceled Celestial AI orders, causing a 45% stock drop. Lead-plaintiff deadline is June 29.
Eos Energy Stock Faces Critical Earnings Test After 26% Surge
Eos Energy Enterprises reports Q1 earnings on May 13 after a sharp rally. Revenue guidance of $56-57M and institutional buying from New Jersey pension fund and Vanguard set the stage.
Everpure's Q1 Report: Analysts Optimistic Amid Rising Supply Costs
Everpure Inc. is set to report its first fiscal Q1 2027 results on May 27, with analysts forecasting a 19% upside, though rising input costs for semiconductors pose a challenge.
Moderna Shares Surge on Hantavirus Vaccine Interest After Andes Virus Outbreak on Cruise Ship
Moderna shares rose nearly 12% after an Andes virus outbreak on a cruise ship drew attention to its early-stage hantavirus vaccine, though WHO rates public risk low.